Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to placebo for the treatment of hypertension: An international, multicenter, randomized, double-blind, placebo- controlled, parallel-group

Project Details

StatusActive
Effective start/end date12/08/2131/12/22

Funding

  • George Clinical: A$2,377.00
  • George Clinical: A$12,331.00
  • George Clinical: A$19,254.00
  • George Clinical: A$13,289.00